HIGH QUALITY SCIENTIFIC CONTENT,  ONLINE OPEN ACCESS,  GLOBAL SCIENTIFIC AUDIENCE,  COST EFFECTIVE, ANY ONE CAN DOWNLOAD REPRINTS 
Spreading knowledge

Google Scholar

Google Scholar

Archives

Back 

PHARMACOVIGILANCE: A RISK MANAGER. Amandeep kaur, H.S Rao, Dinesh Kumar, Pooja Sharma

PHARMACOVIGILANCE: A RISK MANAGER.

Amandeep kaur, H.S Rao, Dinesh Kumar, Pooja Sharma

International Journal of Natural Product Science 2012: Spl Issue 1:203.

Abstract(RBIP-203)

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible medicines related problems. The aim of the pharmacovigilance is making best use of medicines for the treatment or prevention of diseases. Though all medicines should not harm the patients during use but some causes problems. When one patient harms by the use of medicine it loose the trust on the care professional and health system by the patient. To overcome these problems pharmacovigilance is required which identify the risk and risk factors in the shortest possible time. It starts from the clinical stage and continuous throughout the product life cycle of the drug. Modern medicines have changed the way in which diseases are managed and controlled but despite this, these show ADR’s .In order to prevent or reduce the harm to patients ,the mechanism for evaluating and monitoring the safety of medicines in clinical use is vital. Over the last decaded it has been increasingly recognized that the need of pharmacovigilance is necessary to be extended beyond the strict confines of detecting new signals of safety concerns. It also promotes understanding and education and its effective communication to health professionals and the public.
Attachments:
Time to create page: 0.11 seconds


Copyright © All rights reserved Science Instinct Publications sciipub.com